Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study.
Kamperman RG, van Leeuwen EM, Willems M, van der Kooi AJ, Gelderman KA, Hamann D, van Lochem EG, Meek B, van der Molen RG, Platteel AC, Otten HG, Schreurs MW; Dutch Myositis Network; Raaphorst J.
Kamperman RG, et al. Among authors: van der molen rg, van der kooi aj, van leeuwen em, van lochem eg.
J Autoimmun. 2023 Sep;139:103081. doi: 10.1016/j.jaut.2023.103081. Epub 2023 Jun 12.
J Autoimmun. 2023.
PMID: 37393780
No abstract available.